Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.

Mostra altre versioni (1)

Older age has been linked to increased transplant-related mortality from graft-versus-host disease (GvHD). Depletion of T cells from stem cell grafts seems to protect from complications of GvHD particularly in older patients. After myeloablative conditioning, patients with haematological malignancie...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Novitzky, N, Thomas, V, Hale, G, Waldmann, H
Natura:	Journal article
Lingua:	English
Pubblicazione:	2005

Documenti analoghi

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
di: Novitzky, N, et al.
Pubblicazione: (2005)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
di: Novitzky, N, et al.
Pubblicazione: (2004)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
di: Novitzky, N, et al.
Pubblicazione: (2004)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
di: Novitzky, N, et al.
Pubblicazione: (1999)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
di: Novitzky, N, et al.
Pubblicazione: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
di: Novitzky, N, et al.
Pubblicazione: (1997)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
di: Novitzky, N, et al.
Pubblicazione: (2004)

T-cell depletion of peripheral blood progenitor cell grafts is associated with effective protection from GVHD and rapid haematopoietic reconstitution.
di: Novitzky, N, et al.
Pubblicazione: (1997)

In marrow aplasia reduced-intensity conditioning and T-cell depletion of cytokine mobilised stem cells provides good engraftment without GvHD
di: Novitzky, N, et al.
Pubblicazione: (2006)

Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression.
di: Leong, L, et al.
Pubblicazione: (1992)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
di: Novitzky, N, et al.
Pubblicazione: (1997)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
di: Chakrabarti, S, et al.
Pubblicazione: (2003)

Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
di: Mackinnon, S, et al.
Pubblicazione: (1999)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
di: Novitzky, N, et al.
Pubblicazione: (2002)

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
di: Novitzky, N, et al.
Pubblicazione: (2003)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
di: Scott R. Solomon, et al.
Pubblicazione: (2016-01-01)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
di: Davison, G, et al.
Pubblicazione: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
di: Davison, G, et al.
Pubblicazione: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
di: Davison, G, et al.
Pubblicazione: (1998)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
di: Hale, G, et al.
Pubblicazione: (1994)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
di: Jacobs, P, et al.
Pubblicazione: (1994)

Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
di: Russell, N, et al.
Pubblicazione: (1999)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
di: Jacobs, P, et al.
Pubblicazione: (1994)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
di: Hale, G, et al.
Pubblicazione: (1988)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
di: Peter van Balen, et al.
Pubblicazione: (2018-02-01)

Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning
di: Hong Wang, et al.
Pubblicazione: (2023-02-01)

Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning
di: Emilie Castermans, et al.
Pubblicazione: (2008-02-01)

The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
di: Kristin J. Skaarud, et al.
Pubblicazione: (2025-01-01)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
di: Cobbold, S, et al.
Pubblicazione: (1986)

Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
di: Brons, I, et al.
Pubblicazione: (1995)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
di: Hale, G, et al.
Pubblicazione: (1997)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
di: Erden Atilla, et al.
Pubblicazione: (2017-02-01)

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen
di: Annalisa Ruggeri, et al.
Pubblicazione: (2014-09-01)

In vitro and in vivo depletion of T cells.
di: Arnold, R, et al.
Pubblicazione: (1993)

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation
di: Joshua T. Schiffer, et al.
Pubblicazione: (2009-08-01)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
di: Hale, G, et al.
Pubblicazione: (1998)

The effect of myeloablative radiation on urinary bladder mast cells
di: Jessica Smith, et al.
Pubblicazione: (2024-03-01)

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity
di: Sarah J. Stephens, MD, et al.
Pubblicazione: (2016-10-01)

Immune reconstitution following haematopoietic stem cell transplantation.
di: Davison, G, et al.
Pubblicazione: (2000)

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
di: Ron Ram, et al.
Pubblicazione: (2011-08-01)